C12N 15/03
Bacteria
C12N15/03 (Bacteria) appears on 54 US grants and 46 published applications in this corpus.
Search patents in C12N- Granted patents
- 54
- Published applications
- 46
- Assignees
- 36
- Inventors
- 109
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 2 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 2 | 2 |
| 2015 | 6 | 7 |
| 2016 | 5 | 6 |
| 2017 | 7 | 5 |
| 2018 | 3 | 6 |
| 2019 | 1 | 4 |
| 2020 | 4 | 6 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 4 | 1 |
| 2025 | 2 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Chloramphenicol resistant split protein and uses thereof30 Sep 2025US 12,428,637 B2Technology Innovation Momentum Fund (Israel) Limited Partnership
- Bacterial quantitative trait-locus mapping15 Jul 2025US 12,362,039 B2UT-Battelle, LLC
- Method for constructing trehalose multi-enzyme complex in vitro mediated by artificial scaffold protein23 Jul 2024US 12,043,834 B2Qilu University of Technology
- Prokaryotic collagen therapeutics for postoperative adhesions2 Jul 2024US 12,023,419 B2ECM Technologies
- Chloramphenicol resistant split protein and uses thereof19 Mar 2024US 11,932,846 B2Technology Innovation Momentum Fund (Israel) Limited Partnership
- Chimeric genome organisms and methods synthesizing thereof4 Jun 2026US 2026/0152735 A1California Institute of Technology
- Chloramphenicol resistant split protein and uses thereof30 Oct 2025US 2025/0333724 A1Technology Innovation Momentum Fund (Israel) Limited Partnership
- Chloramphenicol resistant split protein and uses thereof19 Dec 2024US 2024/0417716 A1Technology Innovation Momentum Fund (Israel) Limited Partnership
- Method for constructing trehalose multi-enzyme complex in vitro mediated by artificial scaffold protein30 Jun 2022US 2022/0204965 A1Qilu University of Technology
- Bacterial quantitative trait-locus mapping17 Dec 2020US 2020/0395096 A1UT-Battelle, LLC
Most cited
By later US patents
- Methods for rapid microbial detection42US 5,498,525 AAmersham International plc · 1996
- Host cells with artificial endosymbionts34US 8,828,681 B2Bell Biosystems, Inc. · 2014
- Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines26US 6,902,906 B1Acambis Research Limited · 2005
- Process for the improvement of antibiotic production by in vivo genetic recombination25US 4,729,951 ABiogal Gyogyszergyar · 1988
- Host cells with artificial endosymbionts19US 8,859,281 B2Bell Biosystems, Inc. · 2014